Health
HPM to Host Complimentary Webinar on Medical Device Update Year in Review
خلاصہ: HPM to Host Complimentary Webinar on Medical Device Update Year in ReviewHPM to Host Complimentary Webinar on Medical Device Update Year in Review
Anonymous (not verified)
Wed, 11/19/2025 - 00:39
pharmagather item url
HPM to Host Complimentary Webinar on Medical Device Update Year in Review
pharmagather item source
FDA Law Blog
pharmagather item publication date
Wed, 11/19/2025 - 12:00
Source InformationPublisher: Cafe PharmaOriginal Source: Read more
Health
November 18 2025 – Merck advances Winrevair in subset of heart failure patients
خلاصہ: November 18 2025 - Merck advances Winrevair in subset of heart failure patientsNovember 18 2025 - Merck advances Winrevair in subset of heart failure patients
admin
Tue, 11/18/2025 - 11:57
Merck advances Winrevair in subset of heart failure patientsMerck boardVanda tackles Wegovy-driven vomiting, sparking race to phase 3Vanda boardMedtronic lifts forecasts as heart and diabetes devices sell stronglyMedtronic boardRoche extols 'unprecedented' result with breast cancer drugRoche board*please scroll down for all the latest news*Layoff discussionsCheck open job listings in your areaClick here to the top four headlines in your inbox Mon-Fri (free)learn about pharmaceutical fraudlearn about the False Claims Act
image
Source InformationPublisher: Cafe PharmaOriginal Source: Read more
Health
November 17 2025 – J&J, aiming for $50b in cancer sales, buys Halda for $3b in cash
خلاصہ: November 17 2025 - J&J, aiming for $50b in cancer sales, buys Halda for $3b in cashNovember 17 2025 - J&J, aiming for $50b in cancer sales, buys Halda for $3b in cash
admin
Mon, 11/17/2025 - 11:29
J&J, aiming for $50b in cancer sales, buys Halda for $3b in cashJNJ boardNovo Nordisk slashes out-of-pocket prices for Wegovy and OzempicNovo Nordisk boardLilly bets more than $2.6B for South Korea biotech’s bispecific antibody platformEli Lilly boardBMS, J&J give up on milvexian for acute coronary syndromeBristol Myers Squibb board, JNJ board*please scroll down for all the latest news*Layoff discussionsCheck open job listings in your areaClick here to the top four headlines in your inbox Mon-Fri (free)learn about pharmaceutical fraudlearn about the False Claims Act
image
Source InformationPublisher: Cafe PharmaOriginal Source: Read more
Health
Pharma Is Pushing Experience Out the Door — And the Consequences Are Already Here
خلاصہ: Pharma Is Pushing Experience Out the Door — And the Consequences Are Already HerePharma Is Pushing Experience Out the Door — And the Consequences Are Already Here
Anonymous (not verified)
Sat, 11/15/2025 - 15:34
pharmagather item url
Pharma Is Pushing Experience Out the Door — And the Consequences Are Already He…
pharmagather item source
World of DTC Marketing
pharmagather item publication date
Sat, 11/15/2025 - 12:00
Source InformationPublisher: Cafe PharmaOriginal Source: Read more
Health
Huge Channels or No Channels: You Pick
خلاصہ: Huge Channels or No Channels: You PickHuge Channels or No Channels: You Pick
Anonymous (not verified)
Fri, 11/14/2025 - 15:33
pharmagather item url
Huge Channels or No Channels: You Pick
pharmagather item source
In The Pipeline
Source InformationPublisher: Cafe PharmaOriginal Source: Read more
Health
Is Pharma Testing Regulatory Limits with FDA Changes?
خلاصہ: Is Pharma Testing Regulatory Limits with FDA Changes?Is Pharma Testing Regulatory Limits with FDA Changes?
Anonymous (not verified)
Fri, 11/14/2025 - 15:33
pharmagather item url
Is Pharma Testing Regulatory Limits with FDA Changes?
pharmagather item source
World of DTC Marketing
pharmagather item publication date
Fri, 11/14/2025 - 12:00
Source InformationPublisher: Cafe PharmaOriginal Source: Read more
Health
Trump’s consumer-driven healthcare is an irresponsibly destructive idea
خلاصہ: Trump’s consumer-driven healthcare is an irresponsibly destructive ideaTrump’s consumer-driven healthcare is an irresponsibly destructive idea
Anonymous (not verified)
Fri, 11/14/2025 - 03:31
pharmagather item url
Trump’s consumer-driven healthcare is an irresponsibly destructive idea
pharmagather item source
World of DTC Marketing
pharmagather item publication date
Thu, 11/13/2025 - 12:00
Source InformationPublisher: Cafe PharmaOriginal Source: Read more
Health
Biochemical Tungsten – Really
خلاصہ: Biochemical Tungsten - ReallyBiochemical Tungsten - Really
Anonymous (not verified)
Thu, 11/13/2025 - 15:31
pharmagather item url
Biochemical Tungsten - Really
pharmagather item source
In The Pipeline
Source InformationPublisher: Cafe PharmaOriginal Source: Read more
Health
The GLP-1 Hype Train Is Out of Control, and Physicians Are Shoveling the Coal
خلاصہ: The GLP-1 Hype Train Is Out of Control, and Physicians Are Shoveling the CoalThe GLP-1 Hype Train Is Out of Control, and Physicians Are Shoveling the Coal
Anonymous (not verified)
Thu, 11/13/2025 - 12:31
pharmagather item url
The GLP-1 Hype Train Is Out of Control, and Physicians Are Shoveling the Coal
pharmagather item source
World of DTC Marketing
pharmagather item publication date
Thu, 11/13/2025 - 12:00
Source InformationPublisher: Cafe PharmaOriginal Source: Read more
Health
November 13 2025 – Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings
خلاصہ: November 13 2025 - Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filingsNovember 13 2025 - Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filings
admin
Thu, 11/13/2025 - 11:37
Gilead hails phase 3 victory for single-tablet combo of bictegravir and lenacapavir, preps filingsGilead Sciences boardMetsera shareholders vote for up to $10 billion acquisition by PfizerPfizer boardNovo Nordisk faces rare shareholder rebuke over board shake-upNovo Nordisk boardFDA unveils new regulatory roadmap for bespoke drug therapiesPharma/Biotech General Discussion board*please scroll down for all the latest news*Layoff discussionsCheck open job listings in your areaClick here to the top four headlines in your inbox Mon-Fri (free)learn about pharmaceutical fraudlearn about the False Claims Act
image
Source InformationPublisher: Cafe PharmaOriginal Source: Read more
Health
Medicare Part D 2026: Preferred Networks Vanish as the PDP Market Collapses
خلاصہ: Medicare Part D 2026: Preferred Networks Vanish as the PDP Market CollapsesMedicare Part D 2026: Preferred Networks Vanish as the PDP Market Collapses
Anonymous (not verified)
Thu, 11/13/2025 - 09:31
pharmagather item url
Medicare Part D 2026: Preferred Networks Vanish as the PDP Market Collapses
pharmagather item source
Drug Channels
pharmagather item publication date
Thu, 11/13/2025 - 12:00
Source InformationPublisher: Cafe PharmaOriginal Source: Read more
Health
Are GLP-1s Really Extending Cancer Survival—Or Are We Falling for Another Hype Cycle?
خلاصہ: Are GLP-1s Really Extending Cancer Survival—Or Are We Falling for Another Hype Cycle?Are GLP-1s Really Extending Cancer Survival—Or Are We Falling for Another Hype Cycle?
Anonymous (not verified)
Thu, 11/13/2025 - 00:31
pharmagather item url
Are GLP-1s Really Extending Cancer Survival—Or Are We Falling for Another Hype …
pharmagather item source
World of DTC Marketing
pharmagather item publication date
Wed, 11/12/2025 - 12:00
Source InformationPublisher: Cafe PharmaOriginal Source: Read more
Health
Drug Channels Outlook 2026: Live Webinar with Adam J. Fein, Ph.D., on PBMs, Part D, DTC Strategies, Drug Policy Trends, and More
خلاصہ: Drug Channels Outlook 2026: Live Webinar with Adam J. Fein, Ph.D., on PBMs, Part D, DTC Strategies, Drug Policy Trends, and MoreDrug Channels Outlook 2026: Live Webinar with Adam J. Fein, Ph.D., on PBMs, Part D, DTC Strategies, Drug Policy Trends, and More
Anonymous (not verified)
Wed, 11/12/2025 - 09:29
pharmagather item url
Drug Channels Outlook 2026: Live Webinar with Adam J. Fein, Ph.D., on PBMs, Par…
pharmagather item source
Drug Channels
pharmagather item publication date
Wed, 11/12/2025 - 12:00
Source InformationPublisher: Cafe PharmaOriginal Source: Read more
Health
GLP-1s: A Weight Loss Revolution Comes With Challenges & Opportunities
خلاصہ: GLP-1s: A Weight Loss Revolution Comes With Challenges & OpportunitiesGLP-1s: A Weight Loss Revolution Comes With Challenges & Opportunities
Anonymous (not verified)
Wed, 11/12/2025 - 12:29
pharmagather item url
GLP-1s: A Weight Loss Revolution Comes With Challenges & Opportunities
pharmagather item source
World of DTC Marketing
pharmagather item publication date
Wed, 11/12/2025 - 12:00
Source InformationPublisher: Cafe PharmaOriginal Source: Read more
Health
November 12 2025 – Bayer bails on Vividion tumor drug as part of early-stage cancer clear-out
خلاصہ: November 12 2025 - Bayer bails on Vividion tumor drug as part of early-stage cancer clear-outNovember 12 2025 - Bayer bails on Vividion tumor drug as part of early-stage cancer clear-out
admin
Wed, 11/12/2025 - 11:44
Bayer bails on Vividion tumor drug as part of early-stage cancer clear-outBayer boardMedtech VC funding slows in Q3: PitchBookMedtech General Discussion boardAlkermes breaks new ground in narcolepsy with orexin drugAlkermes boardFDA names longtime oncology chief Richard Pazdur as its new CDER directorPharma/Biotech General Discussion board*please scroll down for all the latest news*Layoff discussionsCheck open job listings in your areaClick here to the top four headlines in your inbox Mon-Fri (free)learn about pharmaceutical fraudlearn about the False Claims Act
image
Source InformationPublisher: Cafe PharmaOriginal Source: Read more

